Enabling NeoStem Development

PCT’s mission is to bridge the gap between discovery and patient care by facilitating the transfer of cell-based therapies from laboratory to clinical practice. This includes:

• Proof of principle testing
• Scale up optimization
• Product characterization
• Manufacturing and distribution for all phases of clinical trials
• Commercial modeling, manufacturing and distribution

Now, as a wholly-owned subsidiary of NeoStem, PCT continues to provide these services for a robust pipeline of clients while also lending its expertise to NeoStem’s own product candidates. The effect is to shorten the time and cost of product development and regulatory approval.

Experience

PCT may be the most experienced and successful cell therapy team:

• 30,000+ cell therapy product procedures
• 18,000+ stored cell products
• 14,000+ logistics and transport of cell products for clinical use
• 5,000+ patients received products
• 100+ clients with proven results
• 100+ peer reviewed publications
• 50+ regulatory filings in the US and EU
• 20+ different types of cell products
• 10+ years in business

Future Opportunities

Through its network of contacts throughout the cell therapy industry, PCT is able to identify early stage development opportunities in the cell therapy field and opportunistically develop these cell therapies through proof of concept where they can be further developed and ultimately commercialized through NeoStem’s developing commercial structure.

For more information on PCT, please visit www.pctcelltherapy.com